- « Previous
- 1
- 2
- 3
- 4
Gilead Sciences fails on promise to expand access to lifesaving drug for people living with HIV
June 27, 2019Inaction by US pharmaceutical corporation Gilead to follow through on its so-called ‘access initiative’ leaves people unable to access a vital drug to treat a deadly infection. Delhi/Geneva - Pharmaceutical corporation Gilead Sciences has failed to deliver on promises to make...
Read moreMSF: U.S. Special 301 report undermines efforts to lower medicine prices globally
April 26, 2019On the eve of World Intellectual Property Day, the United States Trade Representative released its annual “Special 301 Report.” Developing countries like India and Malaysia once again face unfair pressure from the US government over the measures these countries have...
Read moreTuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
February 14, 2019Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline. Nandita...
Read moreTuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
February 8, 2019Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline....
Read moreAccess to medicines
February 6, 2019Unaffordable, unavailable, not adapted - people around the world face these challenges in accessing lifesaving medicines. During the 1990s, MSF teams made a bitter observation: we were failing to treat some of our patients suffering from infectious diseases, while in...
Read moreAccess Campaign
January 28, 2019MSF in India: Projects in IndiaAccess campaign Connect with us A worldwide campaign for affordable and effective medicines In 1999, in the wake of Doctors Without Borders / Médecins Sans Frontières (MSF) being awarded the Nobel Peace Prize, MSF launched...
Read moreASEAN and India urged not to trade away people’s lives in trade agreement
July 20, 2018RCEP trade deal could cut medicines lifeline for people in developing countries Bangkok/Geneva - As the sixteen countries negotiating Regional Comprehensive Economic Partnership (RCEP) trade agreement meet in Bangkok this week for another round of closed-door negotiations, public health experts and...
Read moreVaccines: Blueprint ignores high prices and lacks ambition
January 24, 2012Governments meeting at the World Health Organization’s Executive Board (WHO EB) this week must seize the opportunity to improve serious shortcomings in the ‘Decade of Vaccines’ blueprint that will drive the global community’s vaccines response in the next few years. ...
Read more